Azione 002390 GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Guizhou Xinbang Pharmaceutical Co., Ltd.

Azioni

002390

CNE100000NG5

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 26/04/2024 		Variaz. 5gg Var. 1 gen.
3,85 CNY +1,05% Grafico intraday di Guizhou Xinbang Pharmaceutical Co., Ltd. +3,49% -13,29%
15/04 Guizhou Xinbang Pharmaceutical Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023 CI
21/02 Guizhou Xinbang Pharmaceutical Co., Ltd. approva le nomine del Consiglio di Amministrazione CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Board Appointments
Xinbang Pharma Chairman Buys 14 Million Yuan More Shares
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Guizhou Xinbang Pharmaceutical Co., Ltd. commences an Equity Buyback Plan for 14,705,882 shares, representing 0.76% for CNY 200 million, under the authorization approved on July 13, 2023.
Guizhou Xinbang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component Index
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component A Share Index
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 30 May 2023
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Final Dividend for 2022
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Guizhou Xinbang Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Implementation of Final Cash Dividend for 2021, Payable on 24 May 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 002390
  4. Notizie Guizhou Xinbang Pharmaceutical Co., Ltd.
  5. Altre lingue